Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for HIV Prevention Gilead SciencesGilead’s HIV prevention treatment found 100% effective in late-stage trial MarketWatchGilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial CNBCGilead’s long-acting HIV drug superior to daily pill Truvada in study ReutersGilead Shot Prevents 100% of HIV Cases in Trial of African Women Yahoo Finance